Englander Institute for Precision Medicine
Jason Koski/Cornell University

Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease. Yet doctors and scientists have long been vexed by a question: Why do most men whose prostate cancer initially responds to hormonal-blocking therapy later develop a lethal, treatment-resistant form of the disease?

Credit: Nature Communications

Welcome to third quarterly external newsletter of 2025!

ImageThank you for signing up on ...

Claudia Fischbach-Teschl, the James M. and Marsha McCormick Family Director of the Meinig School of Biomedical Engineering, leads the Engineering Innovations in Medicine initiative at Cornell.

Engineering Innovations in Medicine, an initiative launched by Cornell Engineering and Weill Cornell Medicine in 2022 to transform human health through data-driven innovation and interdisciplinary collaboration, will now be led by Claudia Fischbach-Teschl as part of her portfolio as James M. and Marsha McCormick Family Director of the Meinig School of Biomedical Engineering.